South Korea approves its first homemade Covid vaccine for people aged above 18
Vaccine appreared to be more effective than AstraZeneca in generating immune response in trials
The South Korean government has approved the country’s first indigenous Covid-19 vaccine for people aged 18 and above in a major step towards vaccine sovereignty in Seoul’s fight against the pandemic.
The two-dose SKYCovione vaccine, developed by SK Bioscience, was approved after it successfully completed all three phases of its clinical trial and appeared to be more effective than AstraZeneca jabs, according to officials at the country’s Food and Drug Safety Ministry.
The third phase of trial was conducted in Thailand, Vietnam, New Zealand, Ukraine, the Philippines and South Korea.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies